AMETEK executive granted options and restricted stock
AMETEK executive Thomas C. Marecic, President – Electronic Instruments, received new equity awards in the form of stock options and restricted shares.
Rhea-AI Filing Summary
AMETEK executive Thomas C. Marecic, President – Electronic Instruments, received new equity awards in the form of stock options and restricted shares. He was granted stock options on 3,930 shares of common stock at an exercise price of $212.77 per share, expiring in 2036, which will become exercisable in three equal annual installments beginning on March 18, 2027. He also acquired 1,240 shares of common stock as a restricted stock award issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan. To cover taxes on the equity compensation, 253 shares of common stock were withheld, which is treated as a disposition but not an open-market sale. Following these transactions, Marecic directly owns 45,533 shares of common stock, along with additional holdings through a 401(k) plan and shares held by his wife.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 3,930 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 1,240 | $212.77 | $264K |
| Exercise Price or Tax Liability | Common Stock | 253 | $212.77 | $54K |
| holding | 401k Plan | -- | -- | -- |
| holding | Common Stock/ Serp | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (3)
- F1. Constitutes restricted stock issued under the AMETEK, Inc. 2020 Omnibus Incentive Compensation Plan.
- F2. Represents withholding of shares to pay taxes.
- F3. The stock options will become exercisable in three equal annual installments beginning on March 18, 2027.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did AMETEK (AME) executive Thomas C. Marecic receive?
How do the new AMETEK (AME) stock options for Thomas C. Marecic vest?
What is the exercise price and expiration for Thomas C. Marecic’s new AMETEK options?
AI-generated analysis. How Rhea-AI works. Not financial advice.